These findings suggest that ANGPTL4 is significantly associated with lipid metabolism disorders and intraocular pathological changes in PDR patients, indicating that ANGPTL4 may play a crucial role in the onset and progression of PDR. The gene discussed is ANGPTL4; the disease is Disorder of lipid metabolism.